Aptose Biosciences Inc. (APTOF)
OTCMKTS
· Delayed Price · Currency is USD
2.310
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT
Aptose Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 6.15 | 9.25 | 36.97 | 39.11 | 117.39 | Upgrade
|
| Short-Term Investments | - | - | 9.99 | 40.01 | 5 | Upgrade
|
| Cash & Short-Term Investments | 6.15 | 9.25 | 46.96 | 79.13 | 122.39 | Upgrade
|
| Cash Growth | -33.51% | -80.30% | -40.65% | -35.35% | 25.40% | Upgrade
|
| Prepaid Expenses | 2.25 | 2.04 | 2.3 | 2.48 | 2.55 | Upgrade
|
| Restricted Cash | 0.56 | - | - | - | - | Upgrade
|
| Other Current Assets | 0.57 | 0.6 | 0.26 | 0.13 | 0.13 | Upgrade
|
| Total Current Assets | 9.53 | 11.89 | 49.52 | 81.74 | 125.08 | Upgrade
|
| Property, Plant & Equipment | 0.6 | 1.1 | 1.51 | 0.79 | 1.14 | Upgrade
|
| Other Intangible Assets | - | - | - | - | 0.05 | Upgrade
|
| Total Assets | 10.13 | 12.99 | 51.03 | 82.53 | 126.26 | Upgrade
|
| Accounts Payable | 1.26 | 6.05 | 6.33 | 1.7 | 2.17 | Upgrade
|
| Accrued Expenses | 2.77 | 8.83 | 5.66 | 6.02 | 4.1 | Upgrade
|
| Current Portion of Leases | 0.43 | 0.39 | 0.3 | 0.46 | 0.54 | Upgrade
|
| Total Current Liabilities | 4.46 | 15.27 | 12.28 | 8.17 | 6.81 | Upgrade
|
| Long-Term Debt | 10.02 | - | - | - | - | Upgrade
|
| Long-Term Leases | 0.19 | 0.62 | 1 | 0.12 | 0.54 | Upgrade
|
| Total Liabilities | 14.67 | 15.89 | 13.29 | 8.29 | 7.35 | Upgrade
|
| Common Stock | 457.4 | 444.81 | 437.52 | 437.39 | 429.52 | Upgrade
|
| Additional Paid-In Capital | 83.34 | 72.15 | 68.87 | 63.67 | 50.86 | Upgrade
|
| Retained Earnings | -540.97 | -515.54 | -464.33 | -422.51 | -357.15 | Upgrade
|
| Comprehensive Income & Other | -4.32 | -4.32 | -4.32 | -4.32 | -4.32 | Upgrade
|
| Shareholders' Equity | -4.54 | -2.9 | 37.74 | 74.24 | 118.92 | Upgrade
|
| Total Liabilities & Equity | 10.13 | 12.99 | 51.03 | 82.53 | 126.26 | Upgrade
|
| Total Debt | 10.64 | 1.02 | 1.3 | 0.57 | 1.07 | Upgrade
|
| Net Cash (Debt) | -4.49 | 8.24 | 45.66 | 78.55 | 121.32 | Upgrade
|
| Net Cash Growth | - | -81.96% | -41.88% | -35.25% | 26.28% | Upgrade
|
| Net Cash Per Share | -6.42 | 36.58 | 222.68 | 396.80 | 667.10 | Upgrade
|
| Filing Date Shares Outstanding | 2.55 | 0.52 | 0.21 | 0.2 | 0.2 | Upgrade
|
| Total Common Shares Outstanding | 2.01 | 0.26 | 0.21 | 0.2 | 0.2 | Upgrade
|
| Working Capital | 5.07 | -3.38 | 37.24 | 73.56 | 118.26 | Upgrade
|
| Book Value Per Share | -2.26 | -10.96 | 183.87 | 362.26 | 602.06 | Upgrade
|
| Tangible Book Value | -4.54 | -2.9 | 37.74 | 74.24 | 118.87 | Upgrade
|
| Tangible Book Value Per Share | -2.26 | -10.96 | 183.87 | 362.26 | 601.81 | Upgrade
|
| Machinery | 0.15 | 0.37 | 0.54 | 0.71 | 0.5 | Upgrade
|
| Leasehold Improvements | 0.17 | 0.21 | 0.18 | 0.18 | 0.18 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.